Press Releases

Diagnocure Acquires Exclusive Worldwide Rights to Gene-Based Tests for Colorectal Cancer
May 1, 2007

Targeted Diagnostics & Therapeutics, Inc. Names
Daniel J. O'Shannessy, Ph.D. to newly created COO Position

- Growing Biotechnology Company Prepares for Next Phase Expansion -
July 12, 2004

New Colon Cancer Test Receives Approval for Patient Testing
Breakthrough Blood Test for Recurrent Cancer
February 6, 2003

Targeted Diagnostics & Therapeutics, Inc. Expands Cancer Test Targets
PA Biotech Company Develops Esophageal and Gastric Cancer Markers
October 31, 2002

Millennium In-Licenses Novel Target For Colorectal Cancer
New Target Builds Company's Portfolio of Cancer Product Candidates
November 26, 2001

NCI Grant to Study Spread of Colorectal Cancer

Published Articles

Jefferson procures $5M grant for cancer study
By John George, Staff Writer, “The Philadelphia Business Journal”
July 1, 2002

Cancer test breakthrough?
Biotech firm reports making headway in colorectal diagnosis
By: John George, Staff Writer, "The Philadelphia Business Journal"
December 21, 2001